JP-PC-MR at table

International Small Companies Strategy

  • Asset Class Equities


The GMO International Small Companies Strategy seeks to generate high total return greater than that of the S&P Developed ex-U.S. Small Cap Index by investing primarily in non-U.S. developed market equities.

The Strategy’s investment approach is grounded in the Global Equity team’s belief that, in the short term, equity markets exhibit exploitable inefficiencies as a result of irrational investor actions, the imperfect flow of information, and the participation of non-economic actors, while in the long term returns are ultimately driven by economic reality. The Strategy aims to take advantage of this inefficiency by utilizing a multi-factor valuation model in conjunction with other methods, such as cross-asset signals and corporate alerts, to identify mispriced equity securities.





Neil Constable

Head of Global Equity

Dr. Constable is the head of GMO’s Global Equity team. Previously at GMO, he was the head of quantitative research and engaged in portfolio management for the Global Equity team’s quantitative products. Prior to joining GMO in 2006, he was a quantitative researcher for State Street Global Markets and a post-doctoral fellow at MIT. Dr. Constable earned his B.S. in Physics from the University of Calgary, his Master’s in Mathematics from Cambridge University, and his Ph.D. in Physics from McGill University.



Fact Sheet
Product Primer
GIPS Compliant Presentation
GIPS Composite Descriptions
Download All


Portfolio Composition
Download All


Risks associated with investing in the Strategy may include Small Company Risk, Market Risk - Equities, Non-U.S. Investment Risk, Currency Risk, and Illiquidity Risk.